Is MENS or MESO more undervalued in 2026?

CirclFi compares Jyong Biotech Ltd. (MENS) and Mesoblast Limited (MESO) using 13 institutional-grade valuation models. MENS has a Quality of Company score of 2.3/10 while MESO scores 1.7/10.

Which is a better buy — MENS or MESO?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do MENS and MESO valuations compare?

MENS at $2.25 and MESO at $14.76 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

MENS vs MESO Valuation Comparison 2026 — Intrinsic Value Analysis

MENS

Biotechnology

Jyong Biotech Ltd.

Quality

2.3

out of 10

Value Trap

—

Price

$2.25

Last close

Models

9/13

Active

MESO

Biotechnology

Mesoblast Limited

Quality

1.7

out of 10

Value Trap

—

Price

$14.76

Last close

Models

10/13

Active

Model-by-Model Comparison

Model	Type	MENS Fair Value	MENS Upside	MESO Fair Value	MESO Upside
Bayesian DCF	Intrinsic	$0.60	-73.5%	$3.91	-73.5%
Earnings Power Value	Intrinsic	—	—	$6.54	-57.8%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$0.17	-92.1%	—	—

🔒

Unlock Full 13-Model Comparison

Access all valuation models for MENS vs MESO — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

MENS vs MESO — Which Stock Is More Undervalued?

MENS scores higher with a 2.3/10 quality rating vs MESO's 1.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Jyong Biotech Ltd. (MENS) and Mesoblast Limited (MESO) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

MENS currently trades at $2.25 with a QOC of 2.3/10, while MESO trades at $14.76 with a QOC of 1.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).